Unichem Laboratories (NSE:UNICHEMLAB) Total Operating Expense: ₹11,253 Mil (TTM As of Mar. 2026)


NSE:UNICHEMLAB Unichem Laboratories Ltd NSE:UNICHEMLAB
65 GF Score
Price ₹474.55
GF Value ₹688.59
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Unichem Laboratories Total Operating Expense?

Unichem Laboratories NSE:UNICHEMLAB +2.78% 65 Total Operating Expense is ₹11,253 Mil as of Mar. 2026. GuruFocus rates NSE:UNICHEMLAB with a GF Score™ of 65/100 and a GF Value™ of ₹688.59 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Unichem Laboratories's Total Operating Expense for the three months ended in Mar. 2026 was ₹2,900 Mil. Unichem Laboratories's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₹11,253 Mil.

Unichem Laboratories Total Operating Expense Related Terms

Unichem Laboratories Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Unichem Laboratories's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Unichem Laboratories Total Operating Expense Chart

Unichem Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,402.95 7,848.28 9,097.80 11,070.00 11,222.50

Unichem Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,686.00 2,908.50 2,738.70 2,705.40 2,900.30
NSE:UNICHEMLAB
65GF Score
Unichem Laboratories Ltd NSE:UNICHEMLAB
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Unichem Laboratories Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹11,253 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ₹11,253 Mil mean?
Unichem Laboratories (NSE:UNICHEMLAB) has a Total Operating Expense of ₹11,253 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Unichem Laboratories and its competitors.
Is Unichem Laboratories' Total Operating Expense too high?
Unichem Laboratories' current Total Operating Expense is ₹11,253 Mil. Overall, Unichem Laboratories has a GF Score™ of 65/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Unichem Laboratories' Total Operating Expense compare to ZTS and UTHR?
Unichem Laboratories' Total Operating Expense of ₹11,253 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Drug Manufacturers company?
A good Total Operating Expense depends on the Drug Manufacturers industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Unichem Laboratories and its competitors. Unichem Laboratories's current Total Operating Expense is ₹11,253 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Unichem Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Unichem Laboratories (NSE:UNICHEMLAB) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹688.59, compared to a current price of ₹474.55 — trading 31.1% below its estimated fair value. The current Total Operating Expense is ₹11,253 Mil. Unichem Laboratories' overall GF Score™ is 65/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Unichem Laboratories (NSE:UNICHEMLAB), the current Total Operating Expense is ₹11,253 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Unichem Laboratories (NSE:UNICHEMLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Unichem Laboratories stock appears to be undervalued. The current stock price of ₹474.55 is trading 31.1% below its estimated GF Value™ of ₹688.59. GuruFocus considers Unichem Laboratories to be Significantly Undervalued.

Key valuation signals for NSE:UNICHEMLAB:

  • Total Operating Expense: ₹11,253 Mil
  • GF Value™: ₹688.59 vs. price of ₹474.55 (31.1% below fair value)
  • GF Score™: 65/100 with 3 warning signs

No single metric tells the full story. See the NSE:UNICHEMLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Unichem Laboratories Business Description

Other Exchanges 506690:India
Address Off. S. V. Road, Unichem Bhavan, Prabhat Estate, Jogeshwari (West), Mumbai, MH, IND, 400 102
Unichem Laboratories Ltd is an India based pharmaceutical company. It manufactures a range of Active Pharmaceutical Ingredients (APIs). The company's products are offered in the areas of gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management. Some of its products include Apixaban, Brimonidine Tartrate, Finofibrate, Glipizide, Piroxicam and others. The company has a market presence with sales in India and outside India, and the majority of the revenue derived from India. Its product categories comprises Formulations and Bulk Drugs and Chemicals.
65GF Score

Get the complete analysis for NSE:UNICHEMLAB

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹474.55
Price
₹688.59
GF Value